4.4 DIRECTORS REPORT OPEN FOR DISCUSSION Call 44 20 7399 2760 DIRECTORS or E-mail: investors@hikma.
com REPORT The Directors submit their Report together with the audited OPERATIONAL financial statements for the 52 weeks ended 31 December 2012. Business Review This report forms the management report for the purposes of Hikma is required by the Companies Act 2006 to set out a fair review the Disclosure and Transparency Rules.
Readers are asked to cross of the business during the year and a description of the principal refer to the Governance Report, Remuneration Report and sections risks and uncertainties facing Hikma, noting the performance and of other relevant reports which are included in this report to the development of Hikma during the year and the position at the year extent necessary to meet Hikmas reporting obligations.
The information that fulls these requirements and which is incorporated in this report by reference, is included in the following sections of the Annual Report: 4.4 COMMITTEE REPORTS REVIEW HIGHLIGHTS 104 Operational 3 A review of the business and strategy and expected future 105 Financial developments is set out in the Chairmans statement on pages 4 and 5, the Chief Executives Review on pages 10 to 16 and 106 Directors theFinancial Review on pages20 to 37 106 Equity 109 Directors Responsibilities 3 The principal risks and uncertainties are setout on pages 38 to 40 and financial risks are described on pages 144 to 148 3 Key financial performance indicators are described on page 17 3 Information on environmental, social andcommunity issues is set out in our Corporate Responsibility report on pages41to 53, which also provides keyperformance indicators in this area 3 The principal operating subsidiaries are setout on page 56 104 HIKMA PHARMACEUTICALS PLC ANNUAL REPORT 2012
